News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cerus Corporation (CERS) Appoints Chrystal Menard as Chief Legal Officer


10/25/2012 9:53:32 AM

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) announced today that Chrystal Menard has been appointed chief legal officer, effective December 3, 2012.

“Chrystal is an ideal choice to succeed Howard Ervin as chief legal officer as we look forward to building on the commercial success of the INTERCEPT Blood System," said William 'Obi' Greenman, Cerus' president and CEO. "She has an in-depth knowledge of both Cerus and INTERCEPT, gained during the years she acted as outside counsel to the company. She also brings substantial experience in representing companies in the life science and medical products industry."

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES